D. E. Shaw & Co., Inc. - AEGERION PHARMACEUTICALS INC ownership

AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 147 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$423,000
-73.9%
31,116
-63.6%
0.00%
-50.0%
Q2 2015$1,622,000
-34.9%
85,481
-10.3%
0.00%
-50.0%
Q1 2015$2,493,000
+201.1%
95,278
+141.1%
0.00%
+100.0%
Q4 2014$828,000
-93.8%
39,523
-90.1%
0.00%
-88.2%
Q3 2014$13,358,000
+77.2%
400,184
+70.4%
0.02%
+54.5%
Q2 2014$7,537,000
-41.0%
234,867
-15.2%
0.01%
-38.9%
Q1 2014$12,770,000
-32.9%
276,888
+3.2%
0.02%
-30.8%
Q4 2013$19,040,000
-9.5%
268,334
+9.3%
0.03%
-21.2%
Q3 2013$21,050,000
+150.6%
245,593
+85.2%
0.03%
+120.0%
Q2 2013$8,400,000132,6280.02%
Other shareholders
AEGERION PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 537,034$38,108,0006.25%
ADVENT INTERNATIONAL, L.P. 547,001$38,815,0004.56%
Perceptive Advisors 447,785$31,775,0003.82%
HealthCor Management, L.P. 850,000$60,316,0003.66%
Rhenman & Partners Asset Management AB 75,000$5,322,0002.08%
KINGDON CAPITAL MANAGEMENT, L.L.C. 580,000$41,157,0001.89%
ISZO CAPITAL LP 33,150$2,352,0001.74%
KINGDON CAPITAL MANAGEMENT, L.L.C. 458,410$32,501,0001.49%
Cupps Capital Management, LLC 277,097$19,662,0001.34%
CABOT WEALTH MANAGEMENT INC 61,987$4,399,0001.15%
View complete list of AEGERION PHARMACEUTICALS INC shareholders